Cite
Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia.
MLA
Crémieux, Pierre Y., et al. “Cost-Minimization Analysis of Once-Weekly versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia.” Journal of Managed Care Pharmacy : JMCP, vol. 10, no. 6, Nov. 2004, pp. 531–37. EBSCOhost, https://doi.org/10.18553/jmcp.2004.10.6.531.
APA
Crémieux, P. Y., Fastenau, J. M., Kosicki, G., Piech, C. T., & Fendrick, A. M. (2004). Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia. Journal of Managed Care Pharmacy : JMCP, 10(6), 531–537. https://doi.org/10.18553/jmcp.2004.10.6.531
Chicago
Crémieux, Pierre Y, John M Fastenau, George Kosicki, Catherine T Piech, and A Mark Fendrick. 2004. “Cost-Minimization Analysis of Once-Weekly versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia.” Journal of Managed Care Pharmacy : JMCP 10 (6): 531–37. doi:10.18553/jmcp.2004.10.6.531.